Clinical Trials Related to Regeneron Pharmaceuticals

Related studies linked through entity extraction aliases.

COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay

Status: COMPLETED
Phase: PHASE3

Dupilumab Skin Barrier Function Study in Atopic Dermatitis

Status: COMPLETED
Phase: PHASE4

Investigating Treatment With Dupilumab in Patients With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED)

Status: COMPLETED
Phase: PHASE2

Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease

Status: COMPLETED
Phase: PHASE2/PHASE3

Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19

Status: COMPLETED
Phase: PHASE1/PHASE2

Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19

Status: TERMINATED
Phase: PHASE3

Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye

Status: COMPLETED
Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Moderate-to-Severe Atopic Hand and Foot Dermatitis (Liberty-AD-HAFT)

Status: COMPLETED
Phase: PHASE3

REGN7257 in Adult Patients With Severe Aplastic Anemia That Is Refractory to or Relapsed on Immunosuppressive Therapy

Status: TERMINATED
Phase: PHASE1

The Effect of Dupilumab on Lung Inflammation and Related Changes in Airway Volumes Detectable by Functional Respiratory Imaging in Patients With Moderate-severe Asthma

Status: COMPLETED
Phase: PHASE4

A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE)

Status: COMPLETED
Phase: PHASE3

Viral Infection in Asthma (VIA) Study

Status: RECRUITING
Phase: PHASE4

Anti-PD-1 Antibody Treatment With Cemiplimab and Radiotherapy in Early-stage Classical Hodgkin Lymphoma

Status: WITHDRAWN
Phase: PHASE2

Efficacy of Dupilumab for Patients With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)

Status: COMPLETED
Phase: PHASE2

Cemiplimab in AlloSCT/SOT Recipients With CSCC

Status: COMPLETED
Phase: PHASE1/PHASE2

Sarilumab COVID-19

Status: COMPLETED
Phase: PHASE3

Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19

Status: COMPLETED
Phase: PHASE2/PHASE3

Anti-VEGF Therapy for Acute Thyroid Eye Disease

Status: COMPLETED
Phase: PHASE2

Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)

Status: RECRUITING
Phase: PHASE2